NASDAQ
SMIHU

Summit Healthcare Acquisition Corp Unit

Shell Companies
Financial Services

Prices are adjusted according to historical splits.

Summit Healthcare Acquisition Corp Unit Stock Price

Vitals

Today's Low:
$12.15
Today's High:
$14.17
Open Price:
$13.99
52W Low:
$8.86
52W High:
$14.17
Prev. Close:
$12.5
Volume:
3106

Company Statistics

Market Cap.:
$0
Book Value:
-0.174
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

Summit Healthcare Acquisition Corp Unit had its IPO on 2021-06-09 under the ticker symbol SMIHU.

The company operates in the Financial Services sector and Shell Companies industry. Summit Healthcare Acquisition Corp Unit has a staff strength of 0 employees.

Stock update

Shares of Summit Healthcare Acquisition Corp Unit opened at $13.99 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $12.15 - $14.17, and closed at $12.15.

This is a -2.8% slip from the previous day's closing price.

A total volume of 3,106 shares were traded at the close of the day’s session.

In the last one week, shares of Summit Healthcare Acquisition Corp Unit have increased by +21.38%.

Summit Healthcare Acquisition Corp Unit's Key Ratios

Summit Healthcare Acquisition Corp Unit has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Summit Healthcare Acquisition Corp Unit’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Summit Healthcare Acquisition Corp Unit's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Summit Healthcare Acquisition Corp Unit’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q3, Summit Healthcare Acquisition Corp Unit’s quarterly earnings growth was a positive 451.4% while revenue growth was a positive 0%.

Summit Healthcare Acquisition Corp Unit’s PE and PEG Ratio

Forward PE
0
Trailing PE
35.1156
PEG

Its diluted EPS in the last 12-months stands at $0.346 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Summit Healthcare Acquisition Corp Unit’s profitability.

Summit Healthcare Acquisition Corp Unit stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Summit Healthcare Acquisition Corp Unit stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$201.49 million
Total Liabilities
$629956.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Summit Healthcare Acquisition Corp Unit ended 2024 with $201.49 million in total assets and $0 in total liabilities. Its intangible assets were valued at $201.49 million while shareholder equity stood at $195.23 million.

Summit Healthcare Acquisition Corp Unit ended 2024 with $0 in deferred long-term liabilities, $629956.00 in other current liabilities, 201200818.00 in common stock, $-5966699.00 in retained earnings and $0 in goodwill. Its cash balance stood at $70097.00 and cash and short-term investments were $70097.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

Summit Healthcare Acquisition Corp Unit’s total current assets stands at $288642.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Summit Healthcare Acquisition Corp Unit's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Summit Healthcare Acquisition Corp Unit paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$12.15
52-Week High
$14.17
52-Week Low
$8.86
Analyst Target Price
$

Summit Healthcare Acquisition Corp Unit stock is currently trading at $12.15 per share. It touched a 52-week high of $14.17 and a 52-week low of $14.17. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $10.22 and 200-day moving average was $9.96 The short ratio stood at 0.09 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 1664.1% are held by institutions.

Frequently Asked Questions About Summit Healthcare Acquisition Corp Unit

The stock symbol (also called stock or share ticker) of Summit Healthcare Acquisition Corp Unit is SMIHU

The IPO of Summit Healthcare Acquisition Corp Unit took place on 2021-06-09

Similar Industry Stocks (Shell Companies)

Last Price
Chg
Chg%
$26.39
1.25
+4.97%
$8.63
0.11
+1.23%
$261.5
-13.75
-5%
$10.17
0
+0.04%
$4349.25
-221.2
-4.84%
Eyenovia Inc (EYEN)
$1.83
0
0%
Jindal Photo Limited (JINDALPHOT)
$367.8
-10.9
-2.88%
$5.77
0.28
+5.1%
$16.15
-0.53
-3.18%
Goff Corp (WNFT)
$0.01
-0
-1.98%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

As of March 16, 2023, Summit Healthcare Acquisition Corp. was acquired by Yisheng Biopharma Co., Ltd., in a reverse merger transaction. Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Address

1 Lyndhurst Tower, Central, Hong Kong